Dregeoside A11 is primarily studied for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in inhibiting pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory conditions. Preliminary studies suggest it may influence signaling pathways such as NF-κB, which plays a key role in inflammation and cell survival. Due to its natural origin and structural profile, it is also of interest in the development of plant-based therapeutics and nutraceuticals targeting metabolic and immune health. Research is ongoing to evaluate its bioavailability and efficacy in preclinical models.